Totally agree. With the utmost respect to fellow posters, there’s no way this company would get taken over for $25. I’m reasonably confident Neuren management values the business in line with what a few of us here (and Karst) do which is $2.-2.5 billion with trofinetide only. With the company on the cusp of FDA approval would they sell for the base price without a 30-40% premium or to add a premium for NNZ-2591? It’s highly doubtful. If I didn’t know anything about the drugs, TAMs, further applicable indications etc then I’d probably be quite happy with $25. But based on what I do know, and sure as hell Neuren knows a lot more than I do, $25 would be a fire sale and Neuren or the big wigs won’t bite. I’m happy knowing that.
- Forums
- ASX - By Stock
- Share Price
Totally agree. With the utmost respect to fellow posters,...
-
- There are more pages in this discussion • 9,276 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.09 |
Change
0.000(0.00%) |
Mkt cap ! $2.184B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 555 | $17.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.00 | 1600 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 555 | 17.950 |
2 | 279 | 17.940 |
1 | 5000 | 17.500 |
1 | 522 | 17.430 |
1 | 60 | 17.200 |
Price($) | Vol. | No. |
---|---|---|
14.000 | 1600 | 1 |
14.590 | 400 | 1 |
14.630 | 251 | 2 |
14.890 | 60 | 7 |
14.990 | 4286 | 2 |
Last trade - 12.33pm 07/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable